Breaking News
June 21, 2018 - How vaping helps even hardened smokers quit
June 21, 2018 - Gaming disorder an official disease condition says WHO
June 21, 2018 - Oxygen consumption in human BAT increases after a meal, shows research
June 21, 2018 - Research finds addictions to be diseases of the brain, not criminal behavior or personality disorders
June 21, 2018 - New study is testing safety and efficacy of glycoside in breaking up kidney stones
June 21, 2018 - Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future
June 21, 2018 - Cells form cage-like structures that trap viruses
June 21, 2018 - Wound protector use linked to significant reduction in surgical site infection
June 21, 2018 - African Americans and Latinos are more likely to be at risk for depression than Whites
June 21, 2018 - Genome study presents new way to track historical demographics of US populations
June 20, 2018 - Study sheds light on the early stages of tumorigenesis
June 20, 2018 - Quick adoption of new diagnostic tests could help NHS to save nearly £7 billion
June 20, 2018 - Mayo Clinic researchers find genetic mutations that increase person’s risk for pancreatic cancer
June 20, 2018 - Chemists invent new method for remote chiral induction
June 20, 2018 - Methadone or buprenorphine associated with reductions in opioid related mortality
June 20, 2018 - New simulation approach predicts efficacy of HIV-prophylaxis medications
June 20, 2018 - Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
June 20, 2018 - Threat of malaria left its mark on the immune system in people with African ancestry
June 20, 2018 - Recent-onset type 2 diabetes may be early expression of pancreatic cancer
June 20, 2018 - Why are vaccines less effective in the developing world?
June 20, 2018 - Study opens new window into cellular events that occur in the brain during absence seizures
June 20, 2018 - Humana and Walgreens to provide easier access to primary care and other services for seniors
June 20, 2018 - ANU research could help find life in Mars and other planets
June 20, 2018 - Multidisciplinary Human-Focused Research
June 20, 2018 - New study finds increase in use of alternative medicines among children
June 20, 2018 - Forgetting plays a positive role in learning, research suggests
June 20, 2018 - Elevated NT-proBNP Found to Up Cardiovascular Risk in T2DM
June 20, 2018 - Genetics Home Reference: White-Sutton syndrome
June 20, 2018 - Canadian team reports success in transplanting hepatitis C organs
June 20, 2018 - Separating migrant children from parents at US border tantamount to child abuse
June 20, 2018 - Study finds more information about how gene linked to ASD affects the brain
June 20, 2018 - Researchers develop portable monitor to detect dangerous drop in white blood cells
June 20, 2018 - Floppy eyelids linked to sleep apnea
June 20, 2018 - Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson
June 20, 2018 - KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay
June 20, 2018 - Study finds growing support to allow pharmacists to write prescriptions
June 20, 2018 - Malnutrition could have major health implications on patients’ surgical outcomes, shows research
June 20, 2018 - LabConnect collaborates with Symphony to support clinical research industry
June 20, 2018 - Italian innovative SME receives 2.5 million Euro from RedSeed Ventures
June 20, 2018 - AHA: Kids Can Drown Quickly and Silently, So Prevention Is Key
June 20, 2018 - Continuous glucose monitors proven cost-effective, add to quality of life for diabetics
June 20, 2018 - Researchers use droplet-sized ‘miniecosystems’ to test therapeutic potential of molecules
June 20, 2018 - New approach could provide objective and easy-to-obtain measure of dietary adherence
June 20, 2018 - Dual-therapy approach can help boost motor recovery in stroke victims
June 20, 2018 - ‘Miracle treatment’ long-term success for babies with diabetes
June 20, 2018 - Rheumatoid Arthritis patients with depression have increased risk of disease flare
June 20, 2018 - NTU launches new research centers to prevent and treat diseases affecting Singaporeans
June 20, 2018 - Merck enters into agreement with HistoCyte Laboratories to distribute cell line reference products
June 20, 2018 - Researchers examine risk factors for opioid dependence in patients undergoing surgery for DS
June 20, 2018 - Study finds substantial variation in cardiovascular risk across India
June 20, 2018 - Kidney donation among carefully-selected older adults poses minimal risks
June 20, 2018 - Effects of atrial fibrillation can be reduced or reversed by losing weight
June 20, 2018 - Allergan’s Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial
June 20, 2018 - The novel insights of proteoglycans in mineralized tissues
June 20, 2018 - Scientists shed light on key aspect of healthy cell division
June 20, 2018 - Circulating bone turnover markers not linked to hip fracture risk, shows study
June 20, 2018 - Scientists obtain key information about proteins from single human cells
June 20, 2018 - Scientists identify novel genes linked with infantile forms of schizophrenia
June 20, 2018 - Low-dose aspirin could help pregnant women with high blood pressure avoid a dangerous condition
June 20, 2018 - Unusual gene provides novel insight into how the brain wires itself
June 20, 2018 - Study finds IV acetaminophen to be no more effective than oral counterpart for colectomy patients
June 20, 2018 - MAARA to celebrate its 50th anniversary with lecture titled ‘The Future of Asthma’
June 20, 2018 - Administration eases way for small businesses to buy insurance in bulk
June 20, 2018 - High-Quality Diet May Decrease Mortality Risk in Cancer Survivors
June 20, 2018 - JAMA editorial on ECG screening and cardiac risks
June 20, 2018 - Study hints at benefits of lifestyle interventions in reducing dementia risk
June 20, 2018 - Low blood levels of vitamin D linked to increased risk of interstitial lung disease
June 20, 2018 - Simple cognitive task after brain injury improves memory function, study finds
June 20, 2018 - Clinical trial targets metastatic colorectal cancer with new combination therapy
June 20, 2018 - Researchers discover pesticide-free way to limit mosquitoes and reduce spread of West Nile virus
June 20, 2018 - Persistent psychological stress contributes to development and progression of vision loss
June 20, 2018 - Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses
June 20, 2018 - Does Salt Water Help Your Cut? And Other Health Myths of Summer
June 20, 2018 - Scientists help identify genetic markers for prostate cancer in global DNA download
June 19, 2018 - Common ingredient in toothpaste and hand wash could contribute to antibiotic resistance
June 19, 2018 - WHO launches multiyear campaign to eliminate use of trans fat
June 19, 2018 - Scientists could build better drugs by learning from bacteria-derived molecules
June 19, 2018 - Comparative silence between firing spikes of neurons reveals what they are really up to
June 19, 2018 - JAK inhibitors associated with aggressive lymphoma
June 19, 2018 - SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis
FDA panel mulls gene therapy for kids with rare eye disease (Update)

FDA panel mulls gene therapy for kids with rare eye disease (Update)

image_pdfDownload PDFimage_print

(HealthDay)—A U.S. Food and Drug Administration advisory panel was poised on Thursday to recommend approval for a gene therapy that could grant the gift of sight to young people with a rare type of inherited vision loss.

Replacing a nonworking gene with a new one is opening a new world for children and teens with the inherited retinal disease called Leber congenital amaurosis.

“This is a gene therapy that can restore some vision to people who have very limited vision or no vision due to the mutation in the RPE65 gene, and as such, it’s a great breakthrough,” said Stephen Rose, chief research officer at the Foundation Fighting Blindness.

For those who have already received the therapy, the treatment has been life-changing.

Eleven-year-old Cole Carper got the treatment when he was 8, according to the Associated Press. Afterwards, “I looked up and said, ‘What are those light things?’ And my mom said, ‘Those are stars,'” he said.

His 13-year-old sister, Caroline, was treated when she was 10. “I saw snow falling and rain falling. I was completely surprised,” she told the wire service. “I thought of water on the ground or snow on the ground. I never thought of it falling.”

If approved by the FDA advisory panel, the treatment would be on its way to becoming the first gene therapy approved for an inherited disease, said Rose. His foundation helped fund the research that led to the treatment. The FDA typically follows the advice of its expert panels.

Only one other gene therapy has so far met FDA approval—a cancer treatment that the agency sanctioned in August.

This type of vision loss is rare and affects about 1,000 people in the United States, Rose said. “But for these individuals who are essentially blind, it’s a huge impact,” he said.

In total, about 200,000 Americans have some type of inherited disease that causes blindness involving some 250 different genes, Rose said.

“We are not restoring 20/20 vision,” he said. “We are restoring functional vision.”

This means that people can be mobile without the need for a guide dog or a cane, Rose said.

Rose said this therapy treats only this one type of vision loss. “There are 22 different genes that can cause Leber congenital amaurosis—RPE65 is only one of them,” he said.

The treatment, voretigene neparvovec (Luxturna), was developed by Philadelphia-based Spark Therapeutics.

Clinical trials using gene therapy, drugs or cell therapy to treat other types of inherited visions are currently going on, Rose said.

This new treatment is proof that replacing a gene in the eye can restore some vision, he said, and along with other therapies, offers hope for people with previously untreatable inherited vision loss.

It has been tried on kids as young as 4, Rose said. “The earlier you treat the better,” he said. “Ideally, you would treat people as early as possible and prevent any retinal degeneration.”

Whether the treatment will last a lifetime isn’t known, Rose said. But people who received the treatment in early trials more than 10 years ago continue to have their sight, he noted.

Dr. Jean Bennett, a professor of ophthalmology at the University of Pennsylvania in Philadelphia, is one of the researchers who is actually giving the treatment.

Using a harmless virus to carry a new, working RPE65 gene, doctors perform microscopic surgery and, with a tube about the width of a human eyelash, implant the new gene into cells in the retina, she explained.

For maximum vision improvement, the procedure has to be done in each eye, Bennett said.

“We think this same procedure would be effective for other genes,” she said. “It would just require that the gene we used be swapped out and replaced with a different gene.”

Dr. Zenia Aguilersa, a pediatric ophthalmologist at Nicklaus Children’s Hospital in Miami, said that the FDA is taking a big step in gene therapy for these genetic eye diseases.

“If we can treat the disease early, we may prevent blindness in all these kids,” Aguilersa said.

It isn’t known how much the treatment will cost or if it will be covered by insurance, Rose said. But the foundation believes that everyone who needs the treatment should get it.

“Our goal is that there will be treatments for individuals who need these treatments such that nobody will ever have to hear: ‘You have retinal degeneration, get a guide dog, learn braille, get a cane,'” Rose said.


Explore further:
Seeing hope: FDA panel considers gene therapy for blindness (Update)

More information:
Jean Bennett, M.D., Ph.D., professor, ophthalmology, University of Pennsylvania, Philadelphia; Stephen Rose, Ph.D., chief research officer, Foundation Fighting Blindness; Zenia Aguilersa, M.D., pediatric ophthalmologist, Nicklaus Children’s Hospital, Miami

For more on inherited retinal disease, visit the American Academy of Ophthalmology.

Tagged with:

About author

Related Articles